HBK Investments LP Form 8.3 - Allergan Plc
14 September 2019 - 12:16AM
UK Regulatory
TIDMIRSH
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note HBK Investments L.P. on
1) behalf of itself, its
subadvisors and its managed
funds
Company dealt in ALLERGAN PLC
Class of relevant security US $0.0001 Ordinary Shares
to which the dealings being
disclosed relate (Note 2)
Date of dealing 12 September 2019
1. INTERESTS AND SHORT POSITIONS
a. Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 100 (0.00%) 29,223 (0.00%)
(2) Derivatives (other than 5,850,000 (1.78%)
options)
(3) Options and agreements 37,200 (0.01%) 36,000 (0.01%)
to purchase/sell
Total 5,887,300 (1.79%) 65,223 (0.01%)
a. Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than
options)
(3) Options and agreements
to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
a. Purchases and sales
Purchase/sale Number of relevant Price per unit
securities (Note 5)
a. Derivatives transactions (other than options transactions)
Product Nature of Number of relevant Price per
name, transaction securities unit
e.g. CFD (Note 6) (Note 7) (Note 5)
Total Increasing long 100,000 USD
Return Swap position 166.5872
a. Options transactions in respect of existing relevant securities
i. Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. date money
e.g. call purchasing, to which American, paid/
option varying the option European received
etc. relates etc. per unit
(Note 7) (Note 5)
i. Exercising
Product name, Number of securities Exercise price
e.g. call per unit (Note
option 5)
a. Other dealings (including transactions in respect of new securities) (Note
4)
Nature of Details Price per unit
transaction (if applicable)
(Note 8) (Note 5)
Ap21
2.OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None.
Is a Supplemental Form 8 attached? (Note 9)
YES
Date of disclosure 13 September 2019
Contact name Jonathan Brown
Telephone number +44 (0)20 7659 1906
If a connected EFM, name of
offeree/offeror with which
connected
If a connected EFM, state
nature of connection (Note
10)
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form
8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product Written, Number of Exercise Type, Expiry date
name, or relevant price e.g.
e.g. call purchased securities to (Note 2) American,
option which the European
option or etc.
derivative
relates
Call Purchased 20,000 USD 135 American 17 Jan 2020
Option
Call Purchased 17,200 USD 120 American 17 Jan 2020
Option
Put Purchased 20,000 USD 130 American 17 Jan 2020
Option
Put Purchased 16,000 USD 120 American 17 Jan 2020
Option
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
1. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
END
(END) Dow Jones Newswires
September 13, 2019 10:16 ET (14:16 GMT)
Allergan (LSE:0Y7T)
Historical Stock Chart
From Apr 2024 to May 2024
Allergan (LSE:0Y7T)
Historical Stock Chart
From May 2023 to May 2024